Cargando…
A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy
Lung cancer is the leading cause of cancer-related deaths worldwide and in China. Screening for lung cancer by low dose computed tomography (LDCT) can reduce mortality but has resulted in a dramatic rise in the incidence of indeterminate pulmonary nodules, which presents a major diagnostic challenge...
Autores principales: | Ye, Maosong, Tong, Lin, Zheng, Xiaoxuan, Wang, Hui, Zhou, Haining, Zhu, Xiaoli, Zhou, Chengzhi, Zhao, Peige, Wang, Yan, Wang, Qi, Bai, Li, Cai, Zhigang, Kong, Feng-Ming (Spring), Wang, Yuehong, Li, Yafei, Feng, Mingxiang, Ye, Xin, Yang, Dawei, Liu, Zilong, Zhang, Quncheng, Wang, Ziqi, Han, Shuhua, Sun, Lihong, Zhao, Ningning, Yu, Zubin, Zhang, Juncheng, Zhang, Xiaoju, Katz, Ruth L., Sun, Jiayuan, Bai, Chunxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924612/ https://www.ncbi.nlm.nih.gov/pubmed/35311112 http://dx.doi.org/10.3389/fonc.2022.853801 |
Ejemplares similares
-
Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm
por: Ye, Maosong, et al.
Publicado: (2021) -
Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer
por: Feng, Mingxiang, et al.
Publicado: (2021) -
Comparative immunological landscape between pre- and early-stage LUAD manifested as ground-glass nodules revealed by scRNA and scTCR integrated analysis
por: Wang, Ziqi, et al.
Publicado: (2023) -
Bronchoscopic transparenchymal nodule access in the diagnosis and management of pulmonary nodules
por: Zhang, Quncheng, et al.
Publicado: (2023) -
Molecular characterization of clinical responses to PD‐1/PD‐L1 inhibitors in non‐small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD‐1 inhibitors in Chinese patients
por: Song, Peng, et al.
Publicado: (2019)